DAFNA Capital Management LLC 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
DAFNA Capital Management LLC disclosed 82 US equity positions worth $393.4m in its Q4 2024 13F filing. The largest position was XBI at 9.1% of the reported book, followed by STXS and RVMD. Against the Q3 2024 filing, it opened 2 new positions, added to 21 and reduced 12 among the top 50 holdings.
What did DAFNA Capital Management LLC own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | XBI SPDR S&P BIOTECH ETF | 9.1% | $35.8m | 397,505 | -1% | reduced | |
| 2 | STXS STEREOTAXIS INC | 7.9% | $31.2m | 13,680,554 | 0% | held | |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 7.0% | $27.6m | 631,176 | 22% | added |
| 4 | ATRC ATRICURE INC | Healthcare | 5.0% | $19.6m | 641,673 | 0% | held |
| 5 | MERUS N V | 4.8% | $19.0m | 451,804 | 10% | added | |
| 6 | CYTK CYTOKINETICS INC | Healthcare | 4.8% | $18.7m | 398,100 | 0% | held |
| 7 | ASND ASCENDIS PHARMA A/S | Healthcare | 3.6% | $14.2m | 103,355 | 15% | added |
| 8 | AXGN AXOGEN INC | Healthcare | 3.5% | $14.0m | 846,882 | -10% | reduced |
| 9 | IBB ISHARES NASDAQ BIOTECH INDX | 3.4% | $13.6m | 102,500 | 0% | held | |
| 10 | 2655787D BLUEPRINT MEDICINES CORP | 3.3% | $13.1m | 149,763 | 23% | added | |
| 11 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 3.3% | $12.8m | 498,827 | 6% | added |
| 12 | XENE XENON PHARMACEUTICALS INC | Healthcare | 2.7% | $10.7m | 273,739 | 0% | held |
| 13 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.5% | $9.8m | 71,615 | 3% | added |
| 14 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 2.4% | $9.3m | 731,363 | -3% | reduced | |
| 15 | BHVN BIOHAVEN LTD | Healthcare | 2.1% | $8.2m | 220,235 | 18% | added |
| 16 | TNDM TANDEM DIABETES CARE INC | Healthcare | 2.0% | $8.0m | 223,208 | 9% | added |
| 17 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.8% | $7.2m | 542,002 | 3% | added |
| 18 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.7% | $6.9m | 811,678 | 12% | added | |
| 19 | URGN UROGEN PHARMA LTD | Healthcare | 1.3% | $5.2m | 492,515 | 7% | added |
| 20 | DXCM DEXCOM INC | Healthcare | 1.3% | $5.1m | 65,552 | 0% | held |
| 21 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.3% | $5.0m | 667,000 | 0% | held |
| 22 | EWTX EDGEWISE THERAPEUTICS INC | 1.3% | $5.0m | 187,140 | -18% | reduced | |
| 23 | ASND ASCENDIS PHARMA A/S | 1.1% | $4.4m | 4,000,000 | 0% | held | |
| 24 | TELA TELA BIO INC | 1.1% | $4.4m | 1,441,029 | – | new | |
| 25 | PROQR THERAPEUTICS N V | 1.1% | $4.2m | 1,567,561 | 73% | added | |
| 26 | KURA KURA ONCOLOGY INC | Healthcare | 1.0% | $3.9m | 448,368 | 10% | added |
| 27 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 1.0% | $3.8m | 254,217 | -1% | reduced |
| 28 | LKFT GALAPAGOS NV | Healthcare | 0.9% | $3.6m | 130,175 | 0% | held |
| 29 | ALKS ALKERMES PLC | Healthcare | 0.9% | $3.5m | 120,700 | 0% | held |
| 30 | PODD INSULET CORP | Healthcare | 0.8% | $3.2m | 12,400 | -22% | reduced |
| 31 | CATBUSD ASTRIA THERAPEUTICS INC | 0.7% | $2.7m | 299,775 | 18% | added | |
| 32 | IMVT IMMUNOVANT INC | Healthcare | 0.7% | $2.7m | 107,996 | 108% | added |
| 33 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.7% | $2.6m | 1,240,118 | 18% | added |
| 34 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.7% | $2.6m | 64,516 | -49% | reduced |
| 35 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.7% | $2.6m | 393,083 | 57% | added |
| 36 | ARAY ACCURAY INC | Healthcare | 0.6% | $2.4m | 1,222,358 | 0% | held |
| 37 | KROS KEROS THERAPEUTICS INC | Healthcare | 0.5% | $2.1m | 130,316 | 77% | added |
| 38 | INGN INOGEN INC | Healthcare | 0.5% | $1.9m | 208,790 | 0% | held |
| 39 | STOK STOKE THERAPEUTICS INC | Healthcare | 0.5% | $1.9m | 171,097 | -18% | reduced |
| 40 | BCAX BICARA THERAPEUTICS INC | 0.5% | $1.8m | 105,500 | – | new | |
| 41 | BWAY BRAINSWAY LTD | 0.5% | $1.8m | 193,208 | -23% | reduced | |
| 42 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.5% | $1.8m | 146,500 | 0% | held |
| 43 | IMTX IMMATICS NV | Healthcare | 0.4% | $1.7m | 245,000 | 69% | added |
| 44 | ALEC ALECTOR INC | Healthcare | 0.4% | $1.7m | 912,928 | 0% | held |
| 45 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 0.4% | $1.7m | 1,704,232 | 0% | held |
| 46 | BCYC BICYCLE THERAPEUTICS PLC | Healthcare | 0.4% | $1.7m | 120,799 | -1% | reduced |
| 47 | 2662247D ITEOS THERAPEUTICS INC | 0.4% | $1.4m | 188,347 | 17% | added | |
| 48 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 0.4% | $1.4m | 371,434 | -25% | reduced |
| 49 | RGLS REGULUS THERAPEUTICS INC | 0.4% | $1.4m | 875,200 | -2% | reduced | |
| 50 | AUTL AUTOLUS THERAPEUTICS PLC | Healthcare | 0.4% | $1.4m | 586,667 | 21% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.